Establishing Partnerships

Partnerships

Forging public-private partnerships with academia, industry, government and public health is essential to bringing innovative vaccine technologies to the market

Accelerating Excellence

Accelerating Excellence

Advancing Canada’s promising vaccine discoveries of public health importance through preclinical to Phase l and/or early-Phase ll clinical evaluation

Canadian Partners

Community

Through support of Canadian partners, PREVENT will achieve commercialization success and generate dependable revenue streams to ensure long-term sustainability

Coordinating training programs

Training Programs

PREVENT fosters a unique learning environment by bringing together internationally recognized expertise and substantial teaching experience in vaccinology and commercialization

nextprev

Pan-Provincial Vaccine Enterprise Inc. (PREVENT) is a national Centre of Excellence for Commercialization and Research (CECR), a not-for-profit organization focused on the development of vaccine technologies

About PREVENT

Accelerating

the growth of Canada’s vaccine industry by establishing comprehensive preclinical and early clinical programs for the development of new or improved vaccines of high public health importance

Ensuring

Canada’s presence at the forefront of vaccine development by fostering partnerships among academic, industry, government, and not-for-profit sectors to mobilize expertise in areas of vaccine commercialization

Advancing

Canada’s vaccine research and development by identifying promising vaccine technologies from Canadian academia and biotech and cultivating them into attractive candidates for commercialization